Navigation Links
Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
Date:8/22/2007

SEATTLE, Aug. 22 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC), today announced they have entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The goal of this CRADA is to develop patented products for the treatment of patients with cancer -- specifically, human monoclonal antibodies (hmAbs), peptides, and small molecules that affect signal transduction through the insulin-like growth factor (IGF) receptor type I (IGF-IR) and the insulin receptor (IR).

Under terms of the CRADA, which is effective for five years beginning July 31, 2007, SM will have an exclusive option to elect an exclusive or non- exclusive commercialization license to any inventions developed under the CRADA. Scientists at SM and CTI will work with scientists at the Protein Interaction Group at the NCI campus in Frederick, Maryland.

"This is important research being conducted by leaders in the field at NCI that may offer advantages over other therapeutics directed at this target. If successful, CTI would have exclusive rights to negotiate with NIH for a product that targets the ligand that activates the IGF receptor, unlike current approaches to IGF inhibition that target the receptor directly," said James A. Bianco, M.D., President and CEO of Cell Therapeutics, Inc. "This is another exciting addition to several early stage targeted therapies we are evaluating including SRC inhibitors and bisplatinates."

Daniel D. Von Hoff, M.D., Chief Medical Advisor to SM, Physician-in-Chief and Director of the Clinical Translational Research Division at the Translational Genomics Research Institute in Phoenix, Arizona and head of CTI's strategic product portfolio committee noted that, "the IGF system plays an important role in many physiological processes, especially in pathological conditions such
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
3. Performance Comparisons of Commercial RT-PCR Systems
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. In Vivo Signal Transduction Pathway Reporting Systems
6. Improved Vectors for PathDetect Trans-Reporting Systems
7. Genetic Reporter Systems
8. Genetic Reporter Systems
9. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
10. Separation Reproducibility With the BioLogic Chromatography Systems
11. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
(Date:11/5/2009)...FREMONT, Calif., Nov. 5 ...S), a leading developer of state-of-the-art geneti...er Sears, Ph.D. has joined the company,s Scientifi...designing and commercializing novel molecular diag...s, and on the development of computational biology...
(Date:11/5/2009)... Brooke Sanders brings a new lo... CA (PRWEB) November 5, 2009 -- Professional Repro...prographics company is pleased to present Brooke S... their graphics/PR specialist. The addition of Bro...tent growth within Professional Reprographics., , ...
(Date:11/4/2009)... ,, ROCKVILLE, Md., Nov. 4 Z...mpany focused on next-generation antibody drug dev...million in Series A funding from New Enterprise As... capital firms. The capital will be used to create...t address two or more biological targets with a si...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
... Young Companies will Present at the Largest Marke...MBRIDGE, Mass., April 22 NSTI and CTSI today anno... for research & development, funding, and comm...h Annual TechConnect Summit, taking place May 4-6,...Houston, Texas. Held in conjunction with the annu...
...INC. (OTC Bulletin Board: ACCP), announced toda...ral mucositis product has been launched in Germany...s European commercial partner, SpePharm, a pan-Eur...o the provision of high medical value medicines in...se from Access Pharmaceuticals Inc, SpePharm is re...
...ent and Innovation , , MOUNTAIN VIEW, Calif., Apr...Sullivan,s Pharmaceuticals & Biotechnology gro... delivery approaches and technologies in cancer tr... insight on factors such as perception, usage, rec...ters, and barriers of leading drug delivery types,...
Other Biology Technology:TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009 2TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009 3TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009 4Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 2Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 3Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 2Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 3
(Date:11/4/2009)...rridors in the cities of Long Beach and Riverside ...eventable childhood asthma, and the true impact of...as likely been underestimated, according to resear...C). , The study, which appears in an online edi...stimated that nine percent of all childhood asthma...
(Date:11/4/2009)...EY, Calif., Oct. 19 Spectros, deve...ng and imaging devices which shed light on life-th...gned exclusive distribution deals for both its T-S...rkets covered include Australia, New Zealand, The...ame, Italy, France, Spain, Portugal, Poland, Greec...
(Date:11/4/2009)...lif., Oct. 23 GenVault Corporation...gement for genomic discovery, medicine and identif... GenVault,s President and CEO, will be presenting ...October 26th and 27th in La Jolla, CA. ,, Durin...rview of the company together with recent customer...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Mylan Launches First Generic Version of Xopenex 28R 29 Inhalation Solution 28Concentrate 29 0 25 25 55877 1Scientists from University of Hawaii at Manoa find genetic marker 55874 1Scientists from University of Hawaii at Manoa find genetic marker 55874 2Promise of nanodiamonds for safer gene therapy 55869 1Promise of nanodiamonds for safer gene therapy 55869 2Promise of nanodiamonds for safer gene therapy 55869 3
... team of Canadian and Finnish scientists has ident...f T-cells, the white blood cells involved in the r...s. The discovery by researchers of the Institute f... Universit de Montral in Canada and the University...on of the journal Immunity could help to combat...
...cientists at The University of Manchester are stri... be used to create stem cell treatments for heart ...ing boost. , All cells that make up the tissues o...are surrounded by a layer of sugars that coat the ... type of cell they are and to respond to the other...
...USTIN, TexasA chemical engineering professor at Th...that has developed a chlorine-tolerant membrane th... increasing access to fresh water and possibly red...ation process more efficient with better membranes... of water, which will expand the availability of c...
Other Biology News:Identification of protein able to stimulate production of T-cells 2Sugar study is sweetener for stem cell science 2New chlorine-tolerant, desalination membrane hopes to boost access to clean water 2
Feature Extraction Software; 1-year license for Commercial from Agilent Technologies
...tem from Molecular Devices provides precise dispen...he system handles a variety of plate formats for d...and is the first to handle 1536-well microplate wa...from four different channels to accommodate up to ...
Dithiothreitol from USB Corp.
...various commercial and lab-prepared glass arrays. ...ntent of the attached nucleic acid targets, and th...e optimal hybridization conditions for glass micro...to consider, it is impossible for one hybridizatio...
Biology Products: